We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+35.87%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$211M
AUM Growth
-$31.9M
Cap. Flow
-$83.2M
Cap. Flow %
-39.42%
Top 10 Hldgs %
8.5%
Holding
499
New
89
Increased
112
Reduced
218
Closed
57

Top Buys

Rank Stock Value
1
DKL icon
Delek Logistics
DKL
+$1.29M
2
WES icon
Western Midstream Partners
WES
+$970K
3
VNOM icon
Viper Energy
VNOM
+$883K
4
CNQ icon
Canadian Natural Resources
CNQ
+$761K
5
EPR icon
EPR Properties
EPR
+$729K

Top Sells

Rank Stock Value
1
BBDC icon
Barings BDC
BBDC
+$2.49M
2
PSEC icon
Prospect Capital
PSEC
+$2.37M
3
BKCC
BlackRock Capital Investment Corporation
BKCC
+$2.34M
4
JQC icon
Nuveen Credit Strategies Income Fund
JQC
+$2.3M
5
WHF icon
WhiteHorse Finance
WHF
+$2.12M

Sector Composition

Rank Sector Weight
1 Healthcare 33.94%
2 Real Estate 15.9%
3 Energy 15.5%
4 Materials 8.79%
5 Financials 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGNX icon
151
MacroGenics
MGNX
$252M
$488K 0.23%
17,484
-16,459
-48% -$286K
GSBD icon
152
Goldman Sachs BDC
GSBD
$984M
$485K 0.23%
29,891
-96,859
-76% -$1.5M
HTGC icon
153
Hercules Capital
HTGC
$2.97B
$483K 0.23%
46,106
-137,717
-75% -$1.4M
BNTX icon
154
BioNTech
BNTX
$23.2B
$481K 0.23%
+7,212
New +$360K
SRNE
155
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$477K 0.23%
75,984
-12,358
-14% -$47.3K
JSD
156
DELISTED
NUVEEN SHORT DURATION CREDIT OPPORTUNITIES FUND
JSD
$474K 0.22%
40,237
-143,848
-78% -$1.65M
RAPT
157
DELISTED
RAPT Therapeutics
RAPT
$472K 0.22%
+2,034
New +$315K
ARCC icon
158
Ares Capital
ARCC
$13.6B
$471K 0.22%
32,579
-122,268
-79% -$1.65M
GERN icon
159
Geron
GERN
$956M
$471K 0.22%
216,199
-23,499
-10% -$35.1K
ARWR icon
160
Arrowhead Research
ARWR
$12.2B
$462K 0.22%
10,705
+5,304
+98% +$187K
GTHX
161
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$461K 0.22%
18,991
+4,428
+30% +$73.2K
VTA
162
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$455K 0.22%
51,080
-176,678
-78% -$1.51M
BSL
163
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$168M
$452K 0.21%
35,176
-138,555
-80% -$1.7M
ITCI
164
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$446K 0.21%
17,392
-10,658
-38% -$216K
TBPH icon
165
Theravance Biopharma
TBPH
$876M
$445K 0.21%
21,198
-5,745
-21% -$148K
DRNA
166
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$444K 0.21%
17,461
+4,031
+30% +$86.8K
APRE icon
167
Aprea Therapeutics
APRE
$7.71M
$443K 0.21%
+572
New +$375K
JFR icon
168
Nuveen Floating Rate Income Fund
JFR
$1.23B
$437K 0.21%
55,360
-200,012
-78% -$1.54M
NSL
169
DELISTED
NUVEEN SENIOR INCM FD
NSL
$437K 0.21%
92,991
-348,500
-79% -$1.59M
SLRC icon
170
SLR Investment Corp
SLRC
$711M
$434K 0.21%
27,138
-102,305
-79% -$1.56M
JRO
171
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$432K 0.2%
55,060
-218,651
-80% -$1.68M
CRSP icon
172
CRISPR Therapeutics
CRSP
$4.66B
$429K 0.2%
5,844
+347
+6% +$20.3K
MYOV
173
DELISTED
Myovant Sciences Ltd.
MYOV
$429K 0.2%
20,817
-3,078
-13% -$41.9K
BDTX icon
174
Black Diamond Therapeutics
BDTX
$103M
$427K 0.2%
+10,134
New +$373K
BCEL
175
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$427K 0.2%
+20,086
New +$355K
5 6
7
8 9

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Virtus ETF Advisers held 499 positions worth $211M, down 13% from $243M the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

Virtus ETF Advisers withdrew a net $83.2M in Q2 2020, closing 57 positions and reducing 218 holdings. Its most notable exit was Tallgrass Energy, LP Class A Shares, an estimated $1.22M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 20% a quarter earlier, followed by Real Estate and Energy.

Against the trend, Virtus ETF Advisers opened a new position in Verastem worth $342K.

  • Virtus ETF Advisers's largest Q2 2020 buy was Verastem: 16,584 shares worth $342K.
  • Virtus ETF Advisers added most to Delek Logistics in Q2 2020, an estimated $1.29M increase.
  • Virtus ETF Advisers's biggest Q2 2020 reduction was Barings BDC, cutting an estimated $2.49M.
  • Virtus ETF Advisers fully exited Tallgrass Energy, LP Class A Shares in Q2 2020, selling an estimated $1.22M.
  • Virtus ETF Advisers's ten largest holdings make up 8.5% of its $211M portfolio in Q2 2020.
  • Virtus ETF Advisers opened 89 new positions and closed 57 in Q2 2020.
  • Virtus ETF Advisers's portfolio value fell 13% quarter-over-quarter to $211M.

Based on Virtus ETF Advisers's 13F filing for Q2 2020, filed 5 Aug 2020.